Fushiki H - Search Results

1

Quantification of mouse pulmonary cancer models by microcomputed tomography imaging.

Fushiki H, Kanoh-Azuma T, Katoh M, Kawabata K, Jiang J, Tsuchiya N, Satow A, Tamai Y, Hayakawa Y. Fushiki H, et al. Cancer Sci. 2009 Aug;100(8):1544-9. doi: 10.1111/j.1349-7006.2009.01199.x. Epub 2009 May 13. Cancer Sci. 2009. PMID: 19459854 Free article.

2

In vivo imaging of obesity-induced inflammation in adipose tissue.

Fushiki H, Hayakawa Y, Gomori A, Seo T, Tewari S, Ozaki S, Yoshimoto R. Fushiki H, et al. Biochem Biophys Res Commun. 2010 Jan 1;391(1):674-8. doi: 10.1016/j.bbrc.2009.11.119. Epub 2009 Dec 4. Biochem Biophys Res Commun. 2010. PMID: 19961831

3

[Reduction of autofluorescence of in vivo fluorescence imaging by using purified diet].

Fushiki H, Hayakawa Y. Fushiki H, et al. Nihon Yakurigaku Zasshi. 2009 Jul;134(1):13-6. doi: 10.1254/fpj.134.13. Nihon Yakurigaku Zasshi. 2009. PMID: 19602781 Japanese. No abstract available.

4

Pre-clinical validation of orthotopically-implanted pulmonary tumor by imaging with 18F-fluorothymidine-positron emission tomography/computed tomography.

Fushiki H, Miyoshi S, Noda A, Murakami Y, Sasaki H, Jitsuoka M, Mitsuoka K, Matsunari I, Nishimura S. Fushiki H, et al. Anticancer Res. 2013 Nov;33(11):4741-9. Anticancer Res. 2013. PMID: 24222108

5

The selective anaplastic lymphoma receptor tyrosine kinase inhibitor ASP3026 induces tumor regression and prolongs survival in non-small cell lung cancer model mice.

Mori M, Ueno Y, Konagai S, Fushiki H, Shimada I, Kondoh Y, Saito R, Mori K, Shindou N, Soga T, Sakagami H, Furutani T, Doihara H, Kudoh M, Kuromitsu S. Mori M, et al. Among authors: fushiki h. Mol Cancer Ther. 2014 Feb;13(2):329-40. doi: 10.1158/1535-7163.MCT-13-0395. Epub 2014 Jan 13. Mol Cancer Ther. 2014. PMID: 24419060

6

Selective M3 muscarinic receptor antagonist inhibits small-cell lung carcinoma growth in a mouse orthotopic xenograft model.

Ami N, Koga K, Fushiki H, Ueno Y, Ogino Y, Ohta H. Ami N, et al. Among authors: fushiki h. J Pharmacol Sci. 2011;116(1):81-8. doi: 10.1254/jphs.10308fp. Epub 2011 Apr 21. J Pharmacol Sci. 2011. PMID: 21512307 Free article.

7

PET imaging for tyrosine kinase inhibitor (TKI) biodistribution in mice.

Fushiki H, Murakami Y, Miyoshi S, Nishimura S. Fushiki H, et al. Methods Mol Biol. 2015;1219:199-206. doi: 10.1007/978-1-4939-1661-0_15. Methods Mol Biol. 2015. PMID: 25308271

8

YM155, a selective survivin suppressant, inhibits tumor spread and prolongs survival in a spontaneous metastatic model of human triple negative breast cancer.

Yamanaka K, Nakata M, Kaneko N, Fushiki H, Kita A, Nakahara T, Koutoku H, Sasamata M. Yamanaka K, et al. Among authors: fushiki h. Int J Oncol. 2011 Sep;39(3):569-75. doi: 10.3892/ijo.2011.1077. Epub 2011 Jun 14. Int J Oncol. 2011. PMID: 21674125

9

Preclinical Evaluation of an Anti-Nectin-4 ImmunoPET Reagent in Tumor-Bearing Mice and Biodistribution Studies in Cynomolgus Monkeys.

Campbell DO, Noda A, Verlinsky A, Snyder J, Fujita Y, Murakami Y, Fushiki H, Miyoshi S, Lacayo S, Cabral E, Yang P, Stover DR, Joseph IB. Campbell DO, et al. Among authors: fushiki h. Mol Imaging Biol. 2016 Oct;18(5):768-75. doi: 10.1007/s11307-016-0953-x. Mol Imaging Biol. 2016. PMID: 27122234

10

[Evaluation of a new anti-cancer drug regimen for endometrial cancer].

Fushiki H, Hidaka T, Hori S, Fujimura M, Yamakawa Y, Izumi R. Fushiki H, et al. Gan To Kagaku Ryoho. 1998 Jan;25(1):75-8. Gan To Kagaku Ryoho. 1998. PMID: 9464332 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

85 results

Search Page